Balasa Dinverno & Foltz’s Rockwell Medical RMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-407
Closed -$92K 266
2020
Q1
$92K Hold
407
0.01% 245
2019
Q4
$109K Hold
407
0.01% 264
2019
Q3
$124K Buy
407
+37
+10% +$11.4K 0.01% 246
2019
Q2
$123K Buy
370
+22
+6% +$11.2K 0.01% 238
2019
Q1
$218K Hold
348
0.03% 229
2018
Q4
$87K Buy
348
+9
+3% +$3.58K 0.01% 218
2018
Q3
$157K Sell
339
-155
-31% -$75.1K 0.02% 239
2018
Q2
$268K Hold
494
0.04% 187
2018
Q1
$283K Hold
494
0.04% 175
2017
Q4
$316K Hold
494
0.05% 166
2017
Q3
$465K Hold
494
0.07% 123
2017
Q2
$431K Buy
494
+28
+6% +$22.9K 0.07% 132
2017
Q1
$321K Buy
466
+27
+6% +$17.8K 0.05% 151
2016
Q4
$316K Buy
439
+100
+29% +$69.1K 0.05% 138
2016
Q3
$250K Buy
339
+14
+4% +$11.3K 0.05% 153
2016
Q2
$271K Sell
325
-19
-6% -$17.7K 0.05% 142
2016
Q1
$284K Buy
344
+71
+26% +$55.8K 0.05% 135
2015
Q4
$307K Buy
273
+2
+0.7% +$2.33K 0.05% 148
2015
Q3
$230K Buy
271
+100
+58% +$145K 0.04% 170
2015
Q2
$303K Sell
171
-4
-2% -$5.08K 0.05% 142
2015
Q1
$211K Hold
175
0.03% 190
2014
Q4
$198K Hold
175
0.03% 189
2014
Q3
$176K Hold
175
0.03% 178
2014
Q2
$231K Buy
175
+4
+2% +$4.81K 0.03% 160
2014
Q1
$238K Hold
171
0.03% 150
2013
Q4
$196K Buy
171
+26
+18% +$35.8K 0.03% 155
2013
Q3
$182K Buy
145
+13
+10% +$8.82K 0.03% 143
2013
Q2
$52K Buy
+132
New +$56K 0.01% 132

Other funds holding RMTI

Balasa Dinverno & Foltz's RMTI Position: Q2 2020 in Review

Balasa Dinverno & Foltz sold out of Rockwell Medical (RMTI) in Q2 2020, closing a stake of 407 shares — an estimated $92K sold.

Balasa Dinverno & Foltz first reported a position in RMTI in Q2 2013 and held it in 28 quarters. The position peaked at $465K in Q3 2017. 79 funds tracked by Wall St. Rank hold RMTI as of Q2 2020.

  • Balasa Dinverno & Foltz reported no remaining Rockwell Medical position as of Q2 2020 after selling out during the quarter.
  • Balasa Dinverno & Foltz sold 407 Rockwell Medical shares in Q2 2020, an estimated $92K.
  • Balasa Dinverno & Foltz first reported a position in Rockwell Medical in Q2 2013 and held it in 28 quarters.
  • Balasa Dinverno & Foltz's Rockwell Medical position peaked at $465K in Q3 2017.
  • 79 funds tracked by Wall St. Rank held Rockwell Medical as of Q2 2020.

Based on Balasa Dinverno & Foltz's 13F filing for Q2 2020, filed 7 Aug 2020.